Injectable platelet rich fibrin: cell content, morphological, and protein characterization
- 367 Downloads
The aim of the present study was to evaluate the blood cell content, morphological aspects, gene expression of type I collagen, and release of growth factors on an injectable platelet rich fibrin (i-PRF).
Materials and methods
Blood samples were collected from 15 volunteers to prepare i-PRF samples. Peripheral blood was used as a control group. Blood clot and i-PRF samples were cultured for 10 days. The supernatant of the samples was collected for ELISA immunoassay quantification of PDGF and VEGF growth factors over periods of 1, 8, 24, 72, and 240 h. I-PRF and blood clot samples were biologically characterized using histological and immunohistochemistry analysis for IL-10, osteocalcin, and TGF-β. Scanning electron microscopy (SEM) was used to inspect the fibrin network and distribution of blood platelets and leukocytes. Reverse transcriptase polymerase chain reaction (RT-PCR) method was used to evaluate gene expression for type I collagen.
A higher concentration of platelets and lymphocytes was recorded in i-PRF than in peripheral blood (p < 0.05). The release of VEGF was higher in blood clot samples (1933 ± 704) than that for i-PRF (852 ± 376; p < 0.001). Immunohistochemistry showed upregulation of TGF-B, IL-10, and osteocalcin in the i-PRF group. RT-PCR showed increased type I collagen gene expression in i-PRF (p < 0.05). SEM images revealed agglomeration of platelets in some regions, while a fibrin networking was noticeable in the entire i-PRF sample.
Injectable platelet rich fibrin becomes a good approach for soft and mineralized tissue healing considering the formation of a three-dimensional fibrin network embedding platelets, leukocytes, type I collagen, osteocalcin, and growth factors. Indeed, the injectable platelet rich fibrin can be indicated in several medical applications regarding bioactivity, simplied technique, and flowable mixing with other biomaterials.
Morphological, cell, and protein characterization of platelet rich fibrin provides a better understanding of the clinical effects and improvement of clinical guidelines for several medical applications. Once well physicochemical and biologically characterized, the use of an injectable platelet rich fibrin can be extended to other applications in the field of orthopedics, periodontics, and implant dentistry on the repairing process of both soft and mineralized tissues.
KeywordsPlatelet rich fibrin Morphology Histopathology Growth factors
This work was supported by the Conselho Nacional de Pesquisa (CNPq) from Brazil in the subject of the project 443840/2014-8.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed/All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e37–e44. https://doi.org/10.1016/j.tripleo.2005.07.008 CrossRefGoogle Scholar
- 4.Sood V, Masamatti SS, Khatri M, Kumar A, Jindal V (2012) Platelet concentrates–part I. Indian J Dent Sci 4(4):123–126Google Scholar
- 6.Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M (2017) Regenerative potential of leucocyte- and platelet-rich fibrin. Part A: intra-bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta-analysis. J Clin Periodontol 44(1):67–82. https://doi.org/10.1111/jcpe.12643 CrossRefGoogle Scholar
- 7.Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M (2017) Regenerative potential of leucocyte- and platelet-rich fibrin. Part B: sinus floor elevation, alveolar ridge preservation and implant therapy. A systematic review. J Clin Periodontol 44(2):225–234. https://doi.org/10.1111/jcpe.12658 CrossRefGoogle Scholar
- 8.Del Corso M, Dohan Ehrenfest DM (2013) Immediate implantation and peri-implant natural bone regeneration (NBR) in the severely resorbed posterior mandible using leukocyte-and platelet-rich fibrin (L-PRF): a 4-year follow-up. http://asnanportal.com/images/dental_report/periodontics-oral-surgery-implants/poseido-201312109-16-delcor-copia.pdf
- 9.Simonpieri A, Del Corso M, Sammartino G, Dohan Ehrenfest DM (2009) The relevance of Choukrounʼs platelet-rich fibrin and metronidazole during complex maxillary rehabilitations using bone allograft. Part II: implant surgery, prosthodontics, and survival. Implant Dent 18(3):220–229. https://doi.org/10.1097/ID.0b013e31819b5e3f CrossRefGoogle Scholar
- 10.Mosesson MW, Siebenlist KR, Meh DA (2006) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936(1):11–30. https://doi.org/10.1111/j.1749-6632.2001.tb03491.x CrossRefGoogle Scholar
- 15.Choukroun J, Ghanaati S (2017) Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients??? Own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg 44:1–9Google Scholar
- 25.Andrade CX, Orrego A, Pinto N (2016) Hematologic profile of four autologous fibrinogen based binder obtained with differents protocols. In :2–3. doi: https://doi.org/10.13140/RG.2.2.27106.12485
- 26.Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e51–e55. https://doi.org/10.1016/j.tripleo.2005.07.010. CrossRefGoogle Scholar
- 27.Dohan Ehrenfest DM, Doglioli P, de Peppo GM, Del Corso M, Charrier JB (2010) Choukroun’s platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch Oral Biol 55(3):185–194. https://doi.org/10.1016/j.archoralbio.2010.01.004 CrossRefGoogle Scholar
- 29.Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G (2009) Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 27(1):63–69. https://doi.org/10.1080/08977190802636713. CrossRefGoogle Scholar
- 30.Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJJ, Mouhyi J, Dohan DM (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):299–303. https://doi.org/10.1016/j.tripleo.2005.07.012 CrossRefGoogle Scholar
- 31.Yajamanya SR, Chatterjee A, Babu CN, Karunanithi D (2016) Fibrin network pattern changes of platelet-rich fibrin in young versus old age group of individuals: a cell block cytology study. J Indian Soc Periodontol 20(2):151–156Google Scholar
- 32.Dohan Ehrenfest DM, Pinto NR, Pereda A et al (2017) The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Platelets 29:1–14Google Scholar
- 33.Clark RAF (2006) Fibrin and wound healing. Ann N Y Acad Sci 936(1):355–367. https://doi.org/10.1111/j.1749-6632.2001.tb03522.x CrossRefGoogle Scholar